Minireview: Hexose-6-Phosphate Dehydrogenase and Redox Control of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Hexose-6-phosphate dehydrogenase (H6PDH) is a microsomal enzyme that is able to catalyze the first two reactions of an endoluminal pentose phosphate pathway, thereby generating reduced nicotinamide adenine dinucleotide phosphate (NADPH) within the endoplasmic reticulum. It is distinct from the cytosolic enzyme, glucose-6-phosphate dehydrogenase (G6PDH), using a separate pool of NAD(P)+ and capable of oxidizing several phosphorylated hexoses. It has been proposed to be a NADPH regenerating system for steroid hormone and drug metabolism, specifically in determining the set point of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity, the enzyme responsible for the activation and inactivation of glucocorticoids. 11β-HSD1 is a bidirectional enzyme, but in intact cells displays predominately oxo-reductase activity, a reaction requiring NADPH and leading to activation of glucocorticoids. However, in cellular homogenates or in purified preparations, 11β-HSD1 is exclusively a dehydrogenase. Because H6PDH and 11β-HSD1 are coexpressed in the inner microsomal compartment of cells, we hypothesized that H6PDH may provide 11β-HSD1 with NADPH, thus promoting oxo-reductase activity in vivo. Recently, several studies have confirmed this functional cooperation, indicating the importance of intracellular redox mechanisms for the prereceptor control of glucocorticoid availability. With the increased interest in 11β-HSD1 oxo-reductase activity in the pathogenesis and treatment of several human diseases including insulin resistance and the metabolic syndrome, H6PDH represents an additional novel candidate for intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712 · cited 1×
“activate the mineralocorticoid receptor in vivo (22, 23).”
BackgroundTissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity
Rask, E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1418 · Cited by 655 · cited 1×
“They should also raise increased awareness of the pitfalls of measuring only 11 -dehydrogenase activity in vitro and inferring from this that this is representative of 11-oxo-reductase activity in vivo (42).”
BackgroundLAKSHMI, V., & MONDER, C. (1988) · Endocrinology · doi:10.1210/endo-123-5-2390 · Cited by 311
HAUNER, H., SCHMID, P., & PFEIFFER, E. F. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-4-832 · Cited by 308 · cited 1×
“tissue; here its oxo-reductase activity has been implicated in the pathogenesis of the metabolic syndrome through increased local generation of cortisol facilitating hepatic glucose output (28) and adipocyte differentiation (29).”
BackgroundJamieson, P. M., Chapman, K. E., Edwards, C. R. W., & Seckl, J. R. (1995) · Endocrinology · doi:10.1210/en.136.11.4754 · Cited by 301
Type I Glycogen Storage Diseases: Disorders of the Glucose-6- Phosphatase Complex
Chou, J., Matern, D., Mansfield, B., & Chen, Y.-T. (2002) · Current Molecular Medicine · doi:10.2174/1566524024605798 · Cited by 298 · cited 1×
“Supply of G6P is ensured by the glucose-6-phosphate transporter of the ER, which is specific for G6P (7).”
BackgroundDraper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1214 · Cited by 285 · cited 1×
“candidates are likely to be involved (38).”
Self-citationAlberts, P., Nilsson, C., Selén, G., Engblom, L. O. M., Edling, N. H. M., Norling, S., Klingström, G., Larsson, C., Forsgren, M., Ashkzari, M., et al. (2003) · Endocrinology · doi:10.1210/en.2003-0344 · Cited by 263 · cited 1×
“Inhibition of 11 -HSD1, using selective inhibitors, has resulted in improved insulin sensitivity and weight loss (30, 31), but the factors determining 11 -HSD1 set point and oxo-reductase activity per se have remained elusive.”
BackgroundBujalska, I. J., Kumar, S., Hewison, M., & Stewart, P. M. (1999) · Endocrinology · doi:10.1210/endo.140.7.6868 · Cited by 254 · cited 1×
“(33), where differences in oxoreductase-dehydrogenase activities of 11 -HSD1 in human omental and sc adipose stromal cells could not be explained by differences in G6PDH activity.”
BackgroundSelf-citationGlucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Seckl, J. R. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.359 · Cited by 239 · cited 1×
“Additionally, neuronal cells have also been shown to have bidirectional activity (37).”
Background
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
BÁNHEGYI, G., BAUMEISTER, P., BENEDETTI, A., DONG, D., FU, Y., LEE, A. S., LI, J., MAO, C., MARGITTAI, É., NI, M., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1391.007 · Cited by 262
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
“Although questions remain about the regulation and dysregulation of 11 HSD-1 and its role as cause or effect in visceral obesity (146, 149, 150), this cortisolgenerating system within adipose is significant for its local integration of energy homeostasis under normal conditions and for its potential as a target for ph…”
BackgroundGeay, F., Ferraresso, S., Zambonino-Infante, J. L., Bargelloni, L., Quentel, C., Vandeputte, M., Kaushik, S., Cahu, C. L., & Mazurais, D. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-522 · Cited by 184
“Moreover, our data indicate an increase in the expression of hexose-6-phosphate dehydrogenase (h6pdh) and phosphogluconate dehydrogenase (pgd), enzymes of the pentose phosphate pathway that generate NADPH, in fish fed VD [59,60] (Figure 2).”
BackgroundCooper, M. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1412 · Cited by 183
Self-citationDesbriere, R., Vuaroqueaux, V., Achard, V., Boullu‐Ciocca, S., Labuhn, M., Dutour, A., & Grino, M. (2006) · Obesity · doi:10.1038/oby.2006.92 · Cited by 156
“Because it has been demonstrated in H6PDH and 11 -HSD-1 transfected cells that a modulation of H6PDH mRNA induces parallel changes in oxoreductase activity (8), our findings strongly suggest that the conversion of cortisone to cortisol is increased in the AT of obese patients.”
Tissue Production of Cortisol by 11β‐Hydroxysteroid Dehydrogenase Type 1 and Metabolic Disease
WALKER, B. R., & ANDREW, R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.012 · Cited by 150
Cheung, Y. Y., Kim, S. Y., Yiu, W. H., Pan, C., Jun, H.-S., Ruef, R. A., Lee, E. J., Westphal, H., Mansfield, B. C., & CHOU, J. Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30443 · Cited by 133
“The resulting low G6P concentration in the ER lumen not only deprives the ER of G6P hydrolase activity, but also affects another major metabolic pathway in neutrophils: the endoluminal pentose phosphate pathway, which generates NADPH (45, 46).”
BackgroundBossé, Y., Maghni, K., & Hudson, T. J. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00134.2006 · Cited by 125
Endoplasmic reticulum: A metabolic compartment
Csala, M., Bánhegyi, G., & Benedetti, A. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.050 · Cited by 125
“Nevertheless, under physiological conditions in the ER lumen the native substrates for H6PDH are believed to be G6P and NADP+ [21].”
BackgroundInfluentialTiganescu, A., Walker, E. A., Hardy, R. S., Mayes, A. E., & Stewart, P. M. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.257 · Cited by 122
“11b-HSD1 localizes to the endoplasmic reticulum membrane and requires the cofactor NADPH for oxoreductase activity—provided by the endoluminal enzyme hexose-6-phosphate dehydrogenase (H6PDH; Hewitt et al., 2005).”
MethodSelf-citationHughes, K. A., Webster, S. P., & Walker, B. R. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.4.481 · Cited by 102
Rapid mechanisms of glucocorticoid signaling in the Leydig cell☆
Hu, G., Lian, Q., Lin, H., LATIF, S., Morris, D. J., Hardy, M. P., & GE, R. (2008) · Steroids · doi:10.1016/j.steroids.2007.12.020 · Cited by 104
“This is supported by the fact that knockdown of this enzyme by RNAi does not change the direction of 11 HSD1 [59].”
Jun, H. S., Lee, Y., Cheung, Y. Y., McDermott, D. H., Murphy, P. M., Ravin, S. S. D., Mansfield, B. C., & CHOU, J. Y. (2010) · Blood · doi:10.1182/blood-2009-12-258491 · Cited by 98
Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib
Kim, S. Y., Jun, H. S., Mead, P., Mansfield, B. C., & CHOU, J. Y. (2008) · Blood · doi:10.1182/blood-2007-12-129114 · Cited by 95
“Hydrolysis of G6P by hexose-6phosphate dehydrogenase (50, 51) generates NADPH which regulates the activity of 11βhydroxysteroid dehydrogenase-1 (52).”
BackgroundMarini, C., Ravera, S., Buschiazzo, A., Bianchi, G., Orengo, A. M., Bruno, S., Bottoni, G., Emionite, L., Pastorino, F., Monteverde, E., et al. (2016) · Scientific Reports · doi:10.1038/srep25092 · Cited by 95
Redox Control of Endoplasmic Reticulum Function
Csala, M., Margittai, É., & Bánhegyi, G. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2529 · Cited by 98
Carbon metabolism–mediated myogenic differentiation
Bracha, A. L., Ramanathan, A., Huang, S., Ingber, D. E., & Schreiber, S. L. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.301 · Cited by 85
The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in the inflammatory response
Chapman, K. E., Coutinho, A. E., Gray, M., Gilmour, J. S., Savill, J., & Seckl, J. R. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.031 · Cited by 96
Ong, G. S. Y., & Young, M. J. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0318 · Cited by 81
Uncoupled Redox Systems in the Lumen of the Endoplasmic Reticulum
Piccirella, S., Czegle, I., Lizák, B., Margittai, É., Senesi, S., Papp, E., Csala, M., Fulceri, R., Csermely, P., Mandl, J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509406200 · Cited by 78
Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis
Young, M. J., & Rickard, A. J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.008 · Cited by 77
“G6PD is the first and rate-limiting enzyme of the pentose phosphate pathway and is a critical determinant of the intracellular redox state of the cell (Hewitt et al., 2005).”
BackgroundDepot‐specific Regulation of the Conversion of Cortisone to Cortisol in Human Adipose Tissue
Lee, M., Fried, S. K., Mundt, S. S., Wang, Y., Sullivan, S., Stefanni, A., Daugherty, B. L., & Hermanowski‐Vosatka, A. (2008) · Obesity · doi:10.1038/oby.2008.207 · Cited by 73
“Measurement of HSD activity in intact tissue, as opposed to tissue homogenates, is important because the direction of the HSD reaction depends on the production of its cofactor, nicotinamide adenine dinucleotide phosphate-oxidase (NADPH), by hexose6-phosphate dehydrogenase (H6PDH) within the lumen of the endoplasmic r…”
BackgroundGomez-Sanchez, E. P., Romero, D. G., de Rodriguez, A. F., Warden, M. P., Krozowski, Z., & Gomez-Sanchez, C. E. (2008) · Endocrinology · doi:10.1210/en.2007-0328 · Cited by 66
“Its reductase activity requires reduced nicotinamide adenine dinucleotide phosphate (NADPH) (10).”
BackgroundInfluentialMcNelis, J. C., Manolopoulos, K. N., Gathercole, L. L., Bujalska, I. J., Stewart, P. M., Tomlinson, J. W., & Arlt, W. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00314.2012 · Cited by 66
Self-citationAlberti, L., Girola, A., Gilardini, L., Conti, A., Cattaldo, S., Micheletto, G., & Invitti, C. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803677 · Cited by 77
Walker, E. A., Ahmed, A., Lavery, G. G., Tomlinson, J. W., Kim, S. Y., Cooper, M. S., Ride, J. P., Hughes, B. A., Shackleton, C. H. L., McKiernan, P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704144200 · Cited by 59
Self-citationInsulin and Dexamethasone Dynamically Regulate Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1
Balachandran, A., Guan, H., Sellan, M. E., Uum, S. H. M. V., & Yang, K. (2008) · Endocrinology · doi:10.1210/en.2008-0088 · Cited by 68
Bánhegyi, G., Benedetti, A., Csala, M., & Mandl, J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.028 · Cited by 55
“ratio can be maintained by luminal dehydrogenases, such as hexose-6-phosphate dehydrogenase (H6PDH), because the permeability of the ER membrane to pyridine nucleotides is insignificant [29].”
BackgroundInfluentialBremer, A. A., & Miller, W. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408134-5.00013-5 · Cited by 71
Wake, D. J., Homer, N. Z. M., Andrew, R., & Walker, B. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0819 · Cited by 57
Intra-vascular glucocorticoid metabolism as a modulator of vascular structure and function
Hadoke, P. W. F., Macdonald, L. J., Logie, J. J., Small, G. R., Dover, A. R., & Walker, B. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5427-2 · Cited by 63
Evidence of altered cortisol metabolism in critically ill patients: a prospective study
Venkatesh, B., Cohen, J., Hickman, I. J., Nisbet, J. C., Thomas, P., Ward, G., Hall, J., & Prins, J. B. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0727-7 · Cited by 64
“The oxo-reductase activity seen in intact cells requires NADPH (whose concentrations are determined by cytosolic redox) and leads to the activation of glucocorticoids [37].”
BackgroundJun, H. S., Lee, Y., Song, K., Mansfield, B. C., & CHOU, J. Y. (2011) · Blood · doi:10.1182/blood-2010-08-302059 · Cited by 53
Semjonous, N. M., Sherlock, M., Jeyasuria, P., Parker, K. L., Walker, E. A., Stewart, P. M., & Lavery, G. G. (2011) · Endocrinology · doi:10.1210/en.2010-0957 · Cited by 51
“enzyme NADP to nicotinamide adenine dinucleotide phosphate (reduced) (NADPH) for use within an otherwise oxidizing environment (1).”
BackgroundInfluentialSelf-citationWalker, B. R. (2007) · Proceedings of the Nutrition Society · doi:10.1017/s002966510700523x · Cited by 54
“As yet, it is unclear whether variations in hexose-6-phosphate dehydrogenase activity provide a means for post-transcriptional physiological regulation of 11b-HSD1 activity (Hewitt et al. 2005).”
BackgroundHexose-6-phosphate dehydrogenase: linking endocrinology and metabolism in the endoplasmic reticulum
Bánhegyi, G., Csala, M., & Benedetti, A. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0156 · Cited by 55
“the major – if not the only – enzyme responsible for NADP+ reduction in the ER lumen ( Hewitt et al. 2005 ).”
BackgroundThe Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Liu, Y., Nakagawa, Y., Wang, Y., Liu, L., Du, H., Wang, W., Ren, X., Lutfy, K., & Friedman, T. C. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0004 · Cited by 53
“It further confirms recent findings that describe the importance of H6PDH in the control of 11β-HSD1 as a distinct oxoreductase (Banhegyi et al. 2004, Hewitt et al. 2005, McCormick et al. 2006).”
BackgroundResultRogoff, D., Ryder, J. W., Black, K., Yan, Z., Burgess, S. C., McMillan, D. R., & White, P. C. (2007) · Endocrinology · doi:10.1210/en.2007-0593 · Cited by 55
Wang, Y., Huang, S.-L., Feng, Y., Ning, M.-M., & Leng, Y. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.87 · Cited by 45
Kenneke, J. F., Mazur, C. S., Ritger, S. E., & Sack, T. J. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800211t · Cited by 48
Redox‐based endoplasmic reticulum dysfunction in neurological diseases
Bánhegyi, G., Mandl, J., & Csala, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05571.x · Cited by 51
Nader, N., Ng, S. S. M., Wang, Y., Abel, B. S., Chrousos, G. P., & Kino, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0026751 · Cited by 46
“) gene, encoding an enzyme generating reduced nicotinamide adenine dinucleotide phosphate (NADPH) that is required by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) for the activation of glucocorticoids”
Adrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Rodríguez, C., Puente‐Moncada, N., Reiter, R. J., Sánchez‐Sánchez, A. M., Herrera, F., Rodríguez‐Blanco, J., Duarte‐Olivenza, C., Turos‐Cabal, M., Antolín, I., & Martín, V. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29886 · Cited by 44
Global metabolic effects of glycerol kinase overexpression in rat hepatoma cells
Sriram, G., Rahib, L., He, J.-S., Campos, A. E., Parr, L. S., Liao, J. C., & Dipple, K. M. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.09.008 · Cited by 50
Thieringer, R., & Hermanowski‐Vosatka, A. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.5.911 · Cited by 48
Nashev, L. G., Chandsawangbhuwana, C., Balazs, Z., Atanasov, A. G., Dick, B., Frey, F. J., Baker, M. E., & Odermatt, A. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000561 · Cited by 42
“H6PDH colocalizes with 11b-HSD1 at the lumenal surface of the ER-membrane [10], where H6PDH provides cosubstrate NADPH and strongly stimulates 11b-HSD1 reductase activity [10–14].”
BackgroundMarcolongo, P., Piccirella, S., Senesi, S., Wunderlich, L., Gerin, I., Mandl, J., Fulceri, R., Bánhegyi, G., & Benedetti, A. (2007) · Endocrinology · doi:10.1210/en.2006-1472 · Cited by 44
Lack of Hexose-6-Phosphate Dehydrogenase Impairs Lipid Mobilization from Mouse Adipose Tissue
Bujalska, I. J., Hewitt, K., Hauton, D., Lavery, G. G., Tomlinson, J., Walker, E. A., & Stewart, P. M. (2008) · Endocrinology · doi:10.1210/en.2007-1705 · Cited by 44
Self-citationCzegle, I., Piccirella, S., Senesi, S., Csala, M., Mandl, J., Bánhegyi, G., Fulceri, R., & Benedetti, A. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.10.018 · Cited by 38
p53 enables metabolic fitness and self-renewal of nephron progenitor cells
Li, Y., Liu, J., Li, W., Brown, A. C., Baddoo, M., Li, M. M., Carroll, T. J., Oxburgh, L. H., Feng, Y., & Saifudeen, Z. R. (2015) · Development · doi:10.1242/dev.111617 · Cited by 48
“…glucose from lactate (Yu et al., 1993) H6pd −1.4 Pentose phosphate pathway (PPP) Catalyzes the first two reactions of the PPP, thus generating NADPH (Hewitt et al., 2005); H6pd knockout mice have anomalies in glucose homeostasis and endoplasmic reticulum stress (Zielinska et al., 2011) Gpd1 −2.1…”
BackgroundInfluentialZhang, Y., Zhong, X., Gjoka, Z., Li, Y., Stochaj, W. R., Stahl, M., Kriz, R., Tobin, J. F., Erbe, D. V., & Suri, V. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.12.004 · Cited by 44
Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension
Westgate, C. S. J., Markey, K. A., Mitchell, J., Yiangou, A., Singhal, R., Stewart, P. M., Tomlinson, J., Lavery, G. G., Mollan, S. P., & Sinclair, A. J. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0108 · Cited by 36
Self-citationComposition of the redox environment of the endoplasmic reticulum and sources of hydrogen peroxide
Margittai, É., Enyedi, B., Csala, M., Geiszt, M., & Bánhegyi, G. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.01.032 · Cited by 37
Diet and the role of 11β-hydroxysteroid dehydrogenase-1 on obesity
London, E., & Castonguay, T. W. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.02.012 · Cited by 38
Kim, S. Y., Nguyen, A. D., Gao, J., Murphy, P. M., Mansfield, B. C., & CHOU, J. Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604964200 · Cited by 33
Chan, J., Rabbitt, E. H., Innes, B. A., Bulmer, J. N., Stewart, P. M., Kilby, M. D., & Hewison, M. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0289 · Cited by 34
Self-citationLee, S. E., Kim, J.-M., Jeong, M.-K., Zouboulis, C. C., & Lee, S. H. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12009 · Cited by 32
The cross talk of adrenal and Leydig cell steroids in Leydig cells
Wang, Y., Li, H., Zhu, Q., Li, X., Lin, Z., & Ge, R. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105386 · Cited by 32
Tsugita, M., Iwasaki, Y., Nishiyama, M., Taguchi, T., Shinahara, M., Taniguchi, Y., Kambayashi, M., Terada, Y., & Hashimoto, K. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.07.005 · Cited by 30
Wang, Y., Nakagawa, Y., Liu, L., Wang, W., Ren, X., Anghel, A., Lutfy, K., Friedman, T. C., & Liu, Y. (2010) · Diabetologia · doi:10.1007/s00125-010-1956-9 · Cited by 29
“NADPH is regenerated by hexose-6-phosphate dehydrogenase (H6PDH) [26, 27], a microsomal enzyme located in the lumen of the ER and principally produced in hepatocytes and adipocytes, sites of 11β-HSD1 and GR [28, 29].”
Marcolongo, P., Senesi, S., Gava, B., Fulceri, R., Sorrentino, V., Margittai, É., Lizák, B., Csala, M., Bánhegyi, G., & Benedetti, A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.027 · Cited by 32
Vítků, J., Stárka, L., Bičíková, M., Hill, M., Heráček, J., Kolátorová, L., & Hampl, R. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.07.007 · Cited by 29
“H6PDH then represents another possible target for intervention [84].”
Kardon, T., Senesi, S., Marcolongo, P., Legeza, B., Bánhegyi, G., Mandl, J., Fulceri, R., & Benedetti, A. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.04.045 · Cited by 28
The Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Microglia express functional 11β‐hydroxysteroid dehydrogenase type 1
Gottfried‐Blackmore, A., Sierra, A., Mcewen, B. S., Ge, R., & Bulloch, K. (2010) · Glia · doi:10.1002/glia.21007 · Cited by 27
“H6PD raises the intracellular level of NADPH favoring the reductase activity of 11bHSD-1 observed in several tissues [rev. by (Hewitt et al., 2005)].”
BackgroundCzegle, I., Csala, M., Mandl, J., Benedetti, A., Karádi, I., & Bánhegyi, G. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i4.129 · Cited by 30
7α-Hydroxytestosterone Affects 11β-Hydroxysteroid Dehydrogenase 1 Direction in Rat Leydig Cells
Hu, G., Lian, Q., Chen, B., Prasad, P. V., Kumar, N., Zheng, Z., & Ge, R. (2009) · Endocrinology · doi:10.1210/en.2009-0917 · Cited by 28
Gene Expression and miR Profiles of Human Corneal Fibroblasts in Response to Dexamethasone
Liu, L., Walker, E. A., Kissane, S., Khan, I. J., Murray, P. I., Rauz, S., & Wallace, G. R. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7463 · Cited by 27
Self-citationKoperniku, A., Garcia, A. A., & Mochly‐Rosen, D. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01577 · Cited by 26
Lin, H.-J., Huang, Y.-C., Lin, J.-M., Wu, J.-Y., Chen, L.-A., & Tsai, F. (2012) · Ophthalmologica · doi:10.1159/000342616 · Cited by 25
Chia, Y. Y., Liong, S. Y., Ton, S. H., & Kadir, K. B. A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.037 · Cited by 25
New therapeutic options for the metabolic syndrome: what's next?
Flordellis, C. S., Ilias, Ι., & Papavassiliou, A. G. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.06.001 · Cited by 24
Ng, B., Sosicka, P., Fenaille, F., Harroche, A., Vuillaumier‐Barrot, S., Porterfield, M., Xia, Z., Wagner, S. M., Bamshad, M. J., Vergnes-Boiteux, M.-C., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.04.013 · Cited by 23
“SLC37A4 also participates in the ERlocalized pentose phosphate pathway (PPP) by providing Glc-6P to hexose-6-phosphate dehydrogenase (H6PD), which catalyzes the first two reactions of ER-localized PPP generating nicotinamide adenine dinucleotide phosphate (NADPH).(12) Pathogenic variants in SLC37A4 cause autosomal rec…”
Background17β-Estradiol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes
Tagawa, N., Yuda, R., Kubota, S., Wakabayashi, M., Yamaguchi, Y., Kiyonaga, D., Mori, N., Minamitani, E., Masuzaki, H., & Kobayashi, Y. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0021 · Cited by 26
“A cofactor, NADPH, supplied by hexose-6-phosphate dehydrogenase (H6PD) in the endoplasmic reticulum, is critical for full activation of 11b-HSD1 (Hewitt et al. 2005, McCormick et al. 2006, Marcolongo et al. 2007).”
BackgroundIntravascular Glucocorticoid Metabolism during Inflammation and Injury in Mice
Dover, A. R., Hadoke, P. W. F., Macdonald, L. J., Miller, E., Newby, D. E., & Walker, B. R. (2007) · Endocrinology · doi:10.1210/en.2006-0996 · Cited by 22
Fan, Z., Du, H., Zhang, M., Meng, Z., Chen, L., & Liu, Y. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.12.010 · Cited by 21
“…regenerated by hexose-6-phosphate dehydrogenase (H6PDH) (Atanasov et al., 2004; Banhegyi et al., 2004), a microsomal enzyme located in the lumen of the endoplasmic reticulum (ER) and principally expressed in hepatocytes and adipocytes (Hewitt et al., 2005; McCormick et al., 2006; Liu et al., 2008).”
BackgroundThe metabolism of steroids, toxins and drugs by 11β-hydroxysteroid dehydrogenase 1
Zhou, H.-Y., Hu, G., Lian, Q., Morris, D. J., & Ge, R. (2011) · Toxicology · doi:10.1016/j.tox.2011.11.012 · Cited by 22
Biochemistry and physiology of hexose-6-phosphate knockout mice
Zielinska, A. E., Walker, E. A., Stewart, P. M., & Lavery, G. G. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.12.004 · Cited by 20
Self-citationResveratrol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes
Tagawa, N., Kubota, S., Kato, I., & Kobayashi, Y. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0066 · Cited by 19
Glycyrrhizic Acid Improves Lipid and Glucose Metabolism in High-Sucrose-Fed Rats
Chandramouli (2011) · Journal of Endocrinology and Metabolism · doi:10.4021/jem39w · Cited by 21
“Thus, the reductase activity of 11β-HSD1 is strongly dependent on the availability of NADPH, which further relies on G6P availability within the ER lumen [14].”
BackgroundInfluentialTagawa, N., Kubota, S., Kobayashi, Y., & Kato, I. (2014) · Steroids · doi:10.1016/j.steroids.2014.11.003 · Cited by 18
“NADPH is supplied to 11b-HSD1 by hexose-6-phosphate dehydrogenase (H6PD), which is colocalized with 11b-HSD1 in the intralumen of the endoplasmic reticulum [15].”
Prince, P. D., Plantamura, Y. S., Geréz, E. M., Höcht, C., Polizio, A. H., Mayer, M. A., Taira, C. A., Fraga, C. G., Galleano, M., & Carranza, A. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.021 · Cited by 18
Ishii, Y., An, K., Nishimura, Y., & Yamada, H. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.046862 · Cited by 16
“There are NAD(P) -dependent dehydrogenases, such as 11 -hydroxysteroid dehydrogenase and hexose-6-phosphate dehydrogenase, in the lumen of the ER (Hewitt et al., 2005).”
BackgroundWang, Q., Zhang, P., & Gao, H.-B. (2009) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-7-39 · Cited by 15
Intestinal inflammation modulates expression of 11β-hydroxysteroid dehydrogenase in murine gut
Vagnerová, K., Kverka, M., Klusoňová, P., Ergang, P., Mikšík, I., Tlaskalová‐Hogenová, H., & Pácha, J. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06732 · Cited by 18
“…has been found in various intact cells (Seckl & Walker 2001), but alterations in the NADPC/NADPH redox potential governed by the metabolism of glucose-6-phosphate via hexose-6-phosphate dehydrogenase seem to determine whether 11HSD1 operates as a reductase or an oxidase (Hewitt et al. 2005).”
The Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 37
Wang, Y., Liu, L., Du, H., Nagaoka, Y., Fan, W., Lutfy, K., Friedman, T. C., Jiang, M., & Liu, Y. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00491.2013 · Cited by 15
“H6PDH is a microsomal enzyme located in the lumen of the endoplasmic reticulum (ER) and principally expressed in insulin target tissues, such as liver and adipose tissues, sites of 11ß-HSD1 and GR expression (20, 30).”
BackgroundSenesi, S., Marcolongo, P., Manini, I., Fulceri, R., Sorrentino, V., Csala, M., Bánhegyi, G., & Benedetti, A. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0028 · Cited by 14
Yan, C., Yang, H., Wang, Y., Dong, Y., Yu, F., Wu, Y., Wang, W., Adaku, U., Lutfy, K., Friedman, T. C., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.57 · Cited by 13
NAFLD Aggravates Septic Shock Due to Inadequate Adrenal Response and 11β-HSDs Dysregulation in Rats
Huang, H., Tsai, M.-H., Lee, F., Lin, T., Chang, C.-C., Chuang, C., Hsu, S., Hou, M., & Huang, Y. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050403 · Cited by 12
“activity of 11β-HSD1 is exerted by oxo-reductase, which transfers 11-DHC to corticosterone by NADPH generated by G6PD or H6PDH [23,24].”
BackgroundOestlund, I., Snoep, J. L., Schiffer, L., Wabitsch, M., Arlt, W., & Storbeck, K. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106436 · Cited by 13
Wang, X., Mick, G. J., Maser, E., & McCormick, K. L. (2011) · Biochemical Journal · doi:10.1042/bj20102069 · Cited by 12
Dienel, G. A. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03113-z · Cited by 11
Tumor-suppressive microRNA-551b-3p targets H6PD to inhibit gallbladder cancer progression
Ji, T., Gao, L., & Yu, Z. (2020) · Cancer Gene Therapy · doi:10.1038/s41417-020-00252-x · Cited by 11
McCormick, K. L., Wang, X., & Mick, G. J. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.04.003 · Cited by 12
[Physiology and molecular mechanism of glucocorticoid action].
Nagalski, A., & Kiersztan, A. (2010) · PubMed · Cited by 22
Wang, D.-Y., Lu, Q., Walsh, S. L., Payne, L. A., Modha, S. S., Scott, M. J., Sweitzer, T. D., Ames, R. S., Krosky, D. J., & Li, H. (2008) · Molecular Biotechnology · doi:10.1007/s12033-008-9050-y · Cited by 10
Metadata
- Authors
- Hewitt, K. N., Walker, E. A., & Stewart, P. M.
- Affiliations
- University of Birmingham (GB)
- ORCID
- Stewart, Paul M.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-06-01
- Volume
- 146
- Issue
- 6
- Pages
- 2539-2543
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2062256053
- Semantic Scholar
- f1688d0d0bec0ec882986aab5aa549e0384f021c
- Cited by
- 149
- References
- 43
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 4 · 2015: 3 · 2014: 7 · 2013: 6 · 2012: 8
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- hexose-6-phosphate dehydrogenase, 11β-hydroxysteroid dehydrogenase type 1, NADPH regeneration, redox regulation, pentose phosphate pathway, endoplasmic reticulum, microsomal enzymes, insulin resistance, metabolic syndrome, steroid hormone metabolism
- MeSH terms
- Animals, Carbohydrate Dehydrogenases, Energy Metabolism, Humans, Oxidation-Reduction, 11-beta-Hydroxysteroid Dehydrogenase Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.